病例报告:在高度活跃的严重肌痛性肌痛症中使用eculizumab,并由严重的感染复杂化
Yufei Deng1, Haocheng Luo1, Chaoyue Zhang1
1Department of Neuromuscular Diseases, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Frontiers in immunology
|August 18, 2025
概括
在四名患有严重感染的患者中,eculizumab有效治疗了高度活跃的严重肌痛性肌痛症 (gMG),显示出显著的得分改善和良好的耐受性. 这项研究支持eculizumab.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 高活性肌痛性肌痛性肌痛症 (gMG) 涉及反复恶化的耐药患者.
- 埃奎利祖马布是一种补充C5抑制剂,已批准用于抗乙胆受体抗体阳性 (AchR+) gMG.
- 在严重感染的gMG患者中缺乏eculizumab的临床证据.
研究的目的:
- 评估eculizumab在高度活跃的有严重感染的gMG患者中的疗效和安全性.
- 为了评估肌痛性严重症-日常生活活动 (MG-ADL) 和定量肌痛性严重症 (QMG) 评分的变化.
- 在治疗期间监测炎症标志物和病原体特征.
主要方法:
- 四个高度活跃的gMG患者的病例系列具有严重的感染.
- 埃奎利祖马布治疗时间为12次注射.
- 评估MG-ADL和QMG得分,炎症标志物 (PCT,CRP,中性粒细胞,淋巴细胞) 和感染病原体 (细菌培养,NGS).
主要成果:
- 平均MG-ADL得分从22降至4.75和QMG得分从30.5降至14的显著降低.
- 在eculizumab治疗期间没有观察到明显的感染恶化.
- 三名患者的气管切除管被切除;没有进一步的肌危机发生.
结论:
- 埃奎利祖马布显示出临床改善,并且在这种患有严重感染的GMG患者队列中耐受良好.
- 这一病例系列为扩大在复杂的GMG病例中使用eculizumab提供了临床参考.
- 需要进一步的研究,以在更大的研究中证实这些发现.
相关概念视频
01:25Endocarditis II: Clinical Features of Infective Endocarditis
929
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
929
01:29Endocarditis IV: Nursing Management
630
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
630
01:27Myocarditis II: Clinical Features and Diagnostic Tests
493
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
01:14Myocarditis III: Medical Management
343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
01:24Nephrotic Syndrome III : Nursing Management
549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269